Synaptic dysfunction and intellectual disability

Advances in Experimental Medicine and Biology

Volumn 970, Issue , 2012, Pages 433-449

  Valnegri, Pamela ^a   Sala, Carlo ^a   Passafaro, Maria ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Dendritic spines; Intellectual disability; Mental retardation; Small GTPases; Synaptic cell adhesion molecules; Synaptopathies

Indexed keywords

AMPA RECEPTOR; BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INTERLEUKIN 1 RECEPTOR; P21 ACTIVATED KINASE 3; PROTEIN FMRP; PROTEIN NCS 1; RAC1 PROTEIN; RAP PROTEIN; RAS PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; AUTISM; CAUSAL ATTRIBUTION; COPY NUMBER VARIATION; DENDRITIC SPINE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; FMR1 GENE; FRAGILE X SYNDROME; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN LIKE 1 GENE; INTRACELLULAR SIGNALING; MOLECULAR PATHOLOGY; MUTATOR GENE; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NLGN GENE; NONHUMAN; NRXN GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; SEX DIFFERENCE; SYNAPTIC TRANSMISSION;

ANIMALS; CELL ADHESION MOLECULES; CHILD; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; INTELLECTUAL DISABILITY; MICE; MONOMERIC GTP-BINDING PROTEINS; MUTATION; NERVE TISSUE PROTEINS; PHENOTYPE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84858145222     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-0932-8_19     Document Type: Article

References (118)

1. Allen, K. M., Gleeson, J. G., Bagrodia, S., Partington, M. W., MacMillan, J. C., Cerione, R. A., Mulley, J. C. & Walsh, C. A. (1998). PAK3 mutation in nonsyndromic X-linked mental retardation. Nature Genetics, 20, 25-30.
2. Arendt, T., Gärtner, U., Seeger, G., Barmashenko, G., Palm, K., Mittmann, T., Yan, L., Hümmeke, M., Behrbohm, J., Brückner, M.K., Holzer, M., Wahle, P. & Heumann, R. (2004). Neuronal activation of Ras regulates synaptic connectivity. European Journal of Neuroscience, 19, 2953-2966.
3. Bahi, N., Friocourt, G., Carrie, A., Graham, M. E., Weiss, J. L., Chafey, P., Fauchereau, F., Burgoyne, R. D. & Chelly, J. (2003). IL1 receptor accessory protein like, a protein involved in X-linked mental retardation, interacts with Neuronal Calcium Sensor-1 and regulates exocytosis. Human Molecular Genetics, 12, 1415-1425.
4. Bernstein, B. W. & Bamburg, J. R. (2010). ADF/cofilin: A functional node in cell biology. Trends in Cell Biology, 20, 187-195.
5. Bienvenu, T., des Portes, V., McDonell, N., Carrié, A., Zemni, R., Couvert, P., Ropers, H. H., Moraine, C., van Bokhoven, H., Fryns, J. P., Allen, K., Walsh, C. A., Boué, J., Kahn, A., Chelly, J. & Beldjord, C. (2000). Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation. American Journal of Medical Genetics, 93, 294-298.
6. Blanpied, T. A. & Ehlers, M. D. (2004). Microanatomy of dendritic spines: Emerging principles of synaptic pathology in psychiatric and neurological disease. Biological Psychiatry, 55, 1121-1127.
7. Blundell, J., Blaiss, C. A., Etherton, M. R., Espinosa, F., Tabuchi, K., Walz, C., Bolliger, M. F., Südhof, T. C. & Powell, C. M. (2010). Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior. Journal of Neuroscience, 30, 2115-2129.
8. Boda, B., Alberi, S., Nikonenko, I., Node-Langlois, R., Jourdain, P., Moosmayer, M., Parisi-Jourdain, L. & Muller, D. (2004). The mental retardation protein PAK3 contributes to synapse formation and plasticity in hippocampus. Journal of Neuroscience, 24, 10816-10825.
9. Boda, B., Dubos, A. & Muller, D. (2010). Signaling mechanisms regulating synapse formation and function in mental retardation. Current Opinion in Neurobiology, 20, 519-527.
10. Boda, B., Jourdain, L. & Muller, D. (2008). Distinct, but compensatory roles of PAK1 and PAK3 in spine morphogenesis. Hippocampus, 18, 857-861.
11. Bokoch, G. M. (2003). Biology of the p21-activated kinases. Annual Review of Biochemistry, 72, 743-781.
12. Boulet, S. L., Schieve, L. A. & Boyle, C. A. (2009). Birth weight and health and developmental outcomes in US children, 1997-2005. Matern Child Health Journal. 2011. Oct:15(7):836-44. doi:10.1007/s10995-009-0538-2.
13. Bradley, E. A., Thompson, A. & Bryson, S. E. (2002). Mental retardation in teenagers: Prevalence data from the Niagara region, Ontario. Canadian Journal of Psychiatry, 47, 652-659.
14. Carrie, A., et al. (1999). A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nature Genetics, 23, 25-31.
15. Chadman, K.K., Gong, S., Scattoni, M. L., Boltuck, S. E., Gandhy, S.U., Heintz, N. & Crawley, J.N. (2008). Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Research, 1, 147-158.
16. Chocholska, S., Rossier, E., Barbi, G. & Kehrer-Sawatzki, H. (2006). Molecular cytogenetic analysis of a familial interstitial deletion Xp22.2-22.3 with a highly variable phenotype in female carriers. American Journal of Medical Genetics A, 140, 604-610.
17. Comoletti, D., De Jaco, A., Jennings, L. L., Flynn, R. E., Gaietta, G., Tsigelny, I., Ellisman, M. H. & Taylor, P. (2004). The Arg451Cys-neuroligin- 3 mutation associated with autism reveals a defect in protein processing. Journal of Neuroscience, 24, 4889-4893.
18. D'Hulst, C. & Kooy, R. F. (2009). Fragile X syndrome: From molecular genetics to therapy. Journal of Medical Genetics, 46, 577-584.
19. Dalva, M. B., McClelland, A. C. & Kayser, M. S. (2007). Cell adhesion molecules: Signalling functions at the synapse. Nature Reviews Neuroscience, 8, 206-220.
20. De Jaco, A., Lin, M. Z., Dubi, N., Comoletti, D., Miller, M. T., Camp, S., Ellisman, M., Butko, M. T., Tsien, R. Y. & Taylor, P. (2010). Neuroligin trafficking deficiencies arising from mutations in the alpha/beta-hydrolase fold protein family. The Journal of Biological Chemistry, 285, 28674-28682.
21. Dean, C. & Dresbach, T. (2006). Neuroligins and neurexins: Linking cell adhesion, synapse formation and cognitive function. Trends in Neurosciences, 29, 21-29.
22. Doussau, F., Gasman, S., Humeau, Y., Vitiello, F., Popoff, M., Boquet, P., Bader, M. F. & Poulain, B. (2000). A Rho-related GTPase is involved in Ca(2+)-dependent neurotransmitter exocytosis. The Journal of Biological Chemistry, 275, 7764-7770.
23. Drews, C. D., Yeargin-Allsopp, M., Decouflé, P. & Murphy, C. C. (1995). Variation in the influence of selected sociodemographic risk factors for mental retardation. American Journal of Public Health, 85, 329-334.
24. Ehninger, D., Li, W., Fox, K., Stryker, M. P. & Silva, A. J. (2008). Reversing neurodevelopmental disorders in adults. Neuron, 60, 950-960.
25. Endris, V., Wogatzky, B., Leimer, U., Bartsch, D., Zatyka, M., Latif, F., Maher, E. R., Tariverdian, G., Kirsch, S., Karch, D. & Rappold, G. A. (2002). The novel Rho-GTPase activating geneMEGAP/srGAP3 has a putative role in severe mental retardation. Proceedings of the National Academy of Sciences of the United States of America, 99, 11754-11759.
26. Eng, C. (2003). PTEN: One gene, many syndromes. Human Mutation, 22, 183-198.
27. Feng, J., Schroer, R., Yan, J., Song, W., Yang, C., Bockholt, A., Cook, E. H., Skinner, C., Schwartz, C. E. & Sommer, S. S. (2006). High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neuroscience Letters, 409, 10-13.
28. Fiala, J. C., Spacek, J. & Harris, K. M. (2002). Dendritic spine pathology: Cause or consequence of neurological disorders? Brain Research: Brain Research Reviews, 39, 29-54.
29. Fu, Z., Lee, S. H., Simonetta, A., Hansen, J., Sheng, M. & Pak, D. T. (2007). Differential roles of Rap1 and Rap2 small GTPases in neurite retraction and synapse elimination in hippocampal spiny neurons. Journal of Neurochemistry, 100, 118-131.
30. Gäddlin, P. O., Finnström, O., Sydsjö, G. & Leijon, I. (2009). Most very low birth weight subjects do well as adults. Acta Paediatrica, 98, 1513-1520.
31. Gambino, F., Pavlowsky, A., Béglé, A., Dupont, J. L., Bahi, N., Courjaret, R., Gardette, R., Hadjkacem, H., Skala, H., Poulain, B., Chelly, J., Vitale, N. & Humeau, Y. (2007). IL1-receptor accessory protein-like 1 (IL1RAPL1), a protein involved in cognitive functions, regulates N-type Ca2+-channel and neurite elongation. Proceedings of the National Academy of Sciences of the United States of America, 104, 9063-9068.
32. Govek, E. E., Newey, S. E., Akerman, C. J., Cross, J. R., Van der Veken, L. & Van Aelst, L. (2004). The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis. Nature Neuroscience, 7, 364-372.
33. Govek, E. E., Newey, S. E. & Van Aelst, L. (2005). The role of the Rho GTPases in neuronal development. Genes and Development, 19, 1-49.
34. Gu, Y. & Stornetta, R. L. (2007). Synaptic plasticity, AMPA-R trafficking, and Ras-MAPK signaling. Acta Pharmacologica Sinica, 28, 928-936.
35. Hamdan, F. F., et al. (2009). Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. The New England Journal of Medicine, 360, 599-605.
36. Hishimoto, A., Liu, Q. R., Drgon, T., Pletnikova, O., Walther, D., Zhu, X. G., Troncoso, J. C. & Uhl, G. R. (2007). Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms. Human Molecular Genetics, 16, 2880-2891.
37. Hu, H., Qin, Y., Bochorishvili, G., Zhu, Y., van Aelst, L. & Zhu, J. J. (2008). Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome. Journal of Neuroscience, 28, 7847-7862.
38. Humeau, Y., Gambino, F., Chelly, J. & Vitale, N. (2009). X-linked mental retardation: Focus on synaptic function and plasticity. Journal of Neurochemistry, 109, 1-14.
39. Iida, J., Ishizaki, H., Okamoto-Tanaka, M., Kawata, A., Sumita, K., Ohgake, S., Sato, Y., Yorifuji, H., Nukina, N., Ohashi, K., Mizuno, K., Tsutsumi, T., Mizoguchi, A., Miyoshi, J., Takai, Y. & Hata, Y. (2007). Synaptic scaffolding molecule alpha is a scaffold to mediate Nmethyl-D-aspartate receptor-dependent RhoA activation in dendrites. Molecular and Cellular Biology, 27, 4388-4405.
40. Jaffe, A. B. & Hall, A. (2005). Rho GTPases: Biochemistry and biology. Annual Review of Cell and Developmental Biology, 21, 247-269.
41. Jaffer, Z. M. & Chernoff, J. (2002). p21-activated kinases: Three more join the Pak. The International Journal of Biochemistry and Cell Biology, 34, 713-717.
42. Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C. & Bourgeron, T. (2003). Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nature Genetics, 34, 27-29.
43. Jamain, S., Radyushkin, K., Hammerschmidt, K., Granon, S., Boretius, S., Varoqueaux, F., Ramanantsoa, N., Gallego, J., Ronnenberg, A., Winter, D., Frahm, J., Fischer, J., Bourgeron, T., Ehrenreich, H. & Brose, N. (2008). Reduced social interaction and ultrasonic communication in a mousemodel of monogenic heritable autism. Proceedings of the National Academy of Sciences of the United States of America, 105, 1710-1715.
44. Kandel, E. R. (2001). The molecular biology of memory storage: A dialogue between genes and synapses. Science, 294, 1030-1038.
45. Kaufman, L., Ayub, M. & Vincent, J. B. (2010). The genetic basis of non-syndromic intellectual disability: A review. Journal of Neurodevelopmental Disorders, 2, 182-209.
46. Kaufmann, W. E. & Moser, H. W. (2000). Dendritic anomalies in disorders associated with mental retardation. Cerebral Cortex, 10, 981-991.
47. Kessels, H. W. & Malinow, R. (2009). Synaptic AMPA receptor plasticity and behavior. Neuron, 61, 340-350.
48. Khelfaoui, M., Denis, C., van Galen, E., de Bock, F., Schmitt, A., Houbron, C., Morice, E., Giros, B., Ramakers, G., Fagni, L., Chelly, J., Nosten-Bertrand, M. & Billuart, P. (2007). Loss of X-linked mental retardation gene oligophrenin1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity. Journal of Neuroscience, 27, 9439-9450.
49. Khelfaoui, M., Pavlowsky, A., Powell, A.D., Valnegri, P., Cheong, K.W., Blandin, Y., Passafaro, M., Jefferys, J. G., Chelly, J. & Billuart, P. (2009). Inhibition of RhoA pathway rescues the endocytosis defects in Oligophrenin1 mouse model of mental retardation. Human Molecular Genetics, 18, 2575-2583.
50. Kim, M. J., Dunah, A. W., Wang, Y. T. & Sheng, M. (2005). Differential roles of NR2A-and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron, 46, 745-760.
51. Kim, J. H., Liao, D., Lau, L. F. & Huganir, R. L. (1998). SynGAP: A synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron, 20, 683-691.
52. Kim, H. G., et al. (2008). Disruption of neurexin 1 associated with autism spectrum disorder. American Journal of Human Genetics, 82, 199-207.
53. Kirov, G., Gumus, D., Chen, W., Norton, N., Georgieva, L., Sari, M., O'Donovan, M.C., Erdogan, F., Owen, M. J., Ropers, H.H. & Ullmann, R. (2008). Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Human Molecular Genetics, 17, 458-465.
54. Krapivinsky, G., Medina, I., Krapivinsky, L., Gapon, S. & Clapham, D. E. (2004). SynGAPMUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptordependent synaptic AMPA receptor potentiation. Neuron, 43, 563-574.
55. Kutsche, K., Yntema, H., Brandt, A., Jantke, I., Nothwang, H.G., Orth, U., Boavida, M.G., David, D., Chelly, J., Fryns, J. P., Moraine, C., Ropers, H. H., Hamel, B. C., van Bokhoven, H. & Gal, A. (2000). Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nature Genetics, 26, 247-250.
56. Lachman, H. M., Fann, C. S., Bartzis, M., Evgrafov, O. V., Rosenthal, R. N., Nunes, E. V., Miner, C., Santana, M., Gaffney, J., Riddick, A., Hsu, C. L. & Knowles, J. A. (2007). Genomewide suggestive linkage of opioid dependence to chromosome 14q. Human Molecular Genetics, 16, 1327-1334.
57. Laumonnier, F., Bonnet-Brilhault, F., Gomot, M., Blanc, R., David, A., Moizard, M. P., Raynaud, M., Ronce, N., Lemonnier, E., Calvas, P., Laudier, B., Chelly, J., Fryns, J. P., Ropers, H.H., Hamel, B.C., Andres, C., Barthélémy, C., Moraine, C. & Briault, S. (2004).X- linkedmental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. American Journal of Human Genetics, 74, 552-557.
58. Lawson-Yuen, A., Saldivar, J. S., Sommer, S. & Picker, J. (2008). Familial deletion within NLGN4 associated with autism and Tourette syndrome. European Journal of Human Genetics, 16, 614-618.
59. Leonard, H. & Wen, X. (2002). The epidemiology of mental retardation: Challenges and opportunities in the new millennium. Mental Retardation and Developmental Disabilities Research Reviews, 8, 117-134.
60. Levitt, P. & Campbell, D. B. (2009). The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. The Journal of Clinical Investigation, 119, 747-754.
61. Lonze, B. E. & Ginty, D. D. (2002). Function and regulation of CREB family transcription factors in the nervous system. Neuron, 35, 605-623.
62. Macarov, M., Zeigler, M., Newman, J. P., Strich, D., Sury, V., Tennenbaum, A. & Meiner, V. (2007). Deletions of VCX-A and NLGN4: A variable phenotype including normal intellect. Journal of Intellectual Disability Research, 51, 329-333.
63. Marshall, C. R., et al. (2008). Structural variation of chromosomes in autism spectrum disorder. American Journal of Human Genetics, 82, 477-488.
64. May, P. A. & Gossage, J. P. (2001). Estimating the prevalence of fetal alcohol syndrome: A summary. Alcohol Research and Health, 25, 159-167.
65. McLaren, J. & Bryson, S. E. (1987). Review of recent epidemiological studies of mental retardation: Prevalence, associated disorders, and etiology. American Journal of Mental Retardation, 92, 243-254.
66. Meng, J., Meng, Y., Hanna, A., Janus, C. & Jia, Z. (2005). Abnormal long-lasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3. Journal of Neuroscience, 25, 6641-6650.
67. Meng, Y., Zhang, Y., Tregoubov, V., Janus, C., Cruz, L., Jackson, M., Lu, W. Y., MacDonald, J. F., Wang, J. Y., Falls, D. L. & Jia, Z. (2002). Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron, 35, 121-133.
68. Moon, S. Y. & Zheng, Y. (2003). Rho GTPase-activating proteins in cell regulation. Trends in Cell Biology, 13, 13-22.
69. Morrow, E. M., et al. (2008). Identifying autism loci and genes by tracing recent shared ancestry. Science, 321, 218-223.
70. Muddashetty, R. S., Kelić, S., Gross, C., Xu, M. & Bassell, G. J. (2007). Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. Journal of Neuroscience, 27, 5338-5348.
71. Nadif Kasri, N. & Van Aelst, L. (2008). Rho-linked genes and neurological disorders. Pflügers Archiv, 455, 787-797.
72. Nakano-Kobayashi, A., Kasri, N. N., Newey, S. E. & Van Aelst, L. (2009). The Rho-linked mental retardation protein OPHN1 controls synaptic vesicle endocytosis via endophilin A1. Current Biology, 19, 1133-1139.
73. Nasu-Nishimura, Y., Hayashi, T., Ohishi, T., Okabe, T., Ohwada, S., Hasegawa, Y., Senda, T., Toyoshima, C., Nakamura, T. & Akiyama, T. (2006). Role of the Rho GTPase-activating protein RICS in neurite outgrowth. Genes to Cells, 11, 607-614.
74. Newey, S. E., Velamoor, V., Govek, E. E. & Van Aelst, L. (2005). Rho GTPases, dendritic structure, and mental retardation. Journal of Neurobiology, 64, 58-74.
75. Niccols, A. (2007). Fetal alcohol syndrome and the developing socio-emotional brain. Brain and Cognition, 65, 135-142.
76. Nimchinsky, E. A., Sabatini, B. L. & Svoboda, K. (2002). Structure and function of dendritic spines. Annual Review of Physiology, 64, 313-353.
77. Nodé-Langlois, R., Muller, D. & Boda, B. (2006). Sequential implication of the mental retardation proteins ARHGEF6 and PAK3 in spine morphogenesis. Journal of Cell Science, 119, 4986-4993.
78. Orloff, M. S. & Eng, C. (2008). Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene, 27, 5387-5397.
79. Pak, D. T., Yang, S., Rudolph-Correia, S., Kim, E. & Sheng, M. (2001). Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP. Neuron, 31, 289-303.
80. Pavlowsky, A., Gianfelice, A., Pallotto, M., Zanchi, A., Vara, H., Khelfaoui, M., Valnegri, P., Rezai, X., Bassani, S., Brambilla, D., Kumpost, J., Blahos, J., Roux, M. J., Humeau, Y., Chelly, J., Passafaro, M., Giustetto, M., Billuart, P. & Sala, C. (2010). A postsynaptic signaling pathway that may account for the cognitive defect due to IL1RAPL1 mutation. Current Biology, 20, 103-115.
81. Pfeiffer, B. E. & Huber, K. M. (2009). The state of synapses in fragile X syndrome. The Neuroscientist, 15, 549-567.
82. Pinto, D., et al. (2010). Functional impact of global rare copy number variation in autism spectrum disorders. Nature, 466, 368-372.
83. Purpura, D. P. (1974). Dendritic spine "dysgenesis" and mental retardation. Science, 186, 1126-1128.
84. Rauch, A., Hoyer, J., Guth, S., Zweier, C., Kraus, C., Becker, C., Zenker, M., Hüffmeier, U., Thiel, C., Rüschendorf, F., Nürnberg, P., Reis, A. & Trautmann, U. (2006). Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. American Journal of Medical Genetics A, 140, 2063-2074.
85. Reeve, S. P., Bassetto, L., Genova, G. K., Kleyner, Y., Leyssen, M., Jackson, F. R. & Hassan, B. A. (2005). The Drosophila fragile X mental retardation protein controls actin dynamics by directly regulating profilin in the brain. Current Biology, 15, 1156-1163.
86. Rex, C. S., Chen, L. Y., Sharma, A., Liu, J., Babayan, A. H., Gall, C. M. & Lynch, G. (2009). Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation. The Journal of Cell Biology, 186, 85-97.
87. Roberts, A., Allanson, J., Jadico, S. K., Kavamura, M. I., Noonan, J., Opitz, J. M., Young, T. & Neri, G. (2006). The cardiofaciocutaneous syndrome. Journal of Medical Genetics, 43, 833-842.
88. Roeleveld, N., Zielhuis, G. A. & Gabree'ls, F. (1997). The prevalence of mental retardation: A critical review of recent literature. Developmental Medicine and Child Neurology, 39, 125-132.
89. Ropers, H. H. (2010). Genetics of early onset cognitive impairment. Annual Review of Genomics and Human Genetics, 11, 161-187.
90. Ropers, H. H. & Hamel, B. C. (2005). X-linked mental retardation. Nature Reviews Genetics, 6, 46-57.
91. Rosenberger, G., Jantke, I., Gal, A. & Kutsche, K. (2003). Interaction of alphaPIX (ARHGEF6) with beta-parvin (PARVB) suggests an involvement of alphaPIX in integrin-mediated signaling. Human Molecular Genetics, 12, 155-167.
92. Rumbaugh, G., Adams, J. P., Kim, J. H. & Huganir, R. L. (2006). SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. Proceedings of the National Academy of Sciences of the United States of America, 103, 4344-4351.
93. Ryu, J., Futai, K., Feliu, M., Weinberg, R. & Sheng, M. (2008). Constitutively active Rap2 transgenic mice display fewer dendritic spines, reduced extracellular signal-regulated kinase signaling, enhanced long-term depression, and impaired spatial learning and fear extinction. Journal of Neuroscience, 28, 8178-8188.
94. Schubbert, S., Bollag, G. & Shannon, K. (2007). Deregulated Ras signaling in developmental disorders: New tricks for an old dog. Current Opinion in Genetics and Development, 17, 15-22.
95. Seidman, L. J., Buka, S. L., Goldstein, J. M., Horton, N. J., Rieder, R. O. & Tsuang, M. T. (2000). The relationship of prenatal and perinatal complications to cognitive functioning at age 7 in the New England Cohorts of the National Collaborative Perinatal Project. Schizophrenia Bulletin, 26, 309-321.
96. Soderling, S. H., Guire, E. S., Kaech, S., White, J., Zhang, F., Schutz, K., Langeberg, L. K., Banker, G., Raber, J. & Scott, J. D. (2007). A WAVE-1 and WRP signaling complex regulates spine density, synaptic plasticity, and memory. Journal of Neuroscience, 27, 355-365.
97. Spohr, H. L., Willms, J. & Steinhausen, H. C. (2007). Fetal alcohol spectrum disorders in young adulthood. The Journal of Pediatrics, 150, 175-179, 179.e171.
98. Stanyon, C. A. & Bernard, O. (1999). LIM-kinase1. The International Journal of Biochemistry and Cell Biology, 31, 389-394.
99. Südhof, T. C. (2008). Neuroligins and neurexins link synaptic function to cognitive disease. Nature, 455, 903-911.
100. Szatmari, P., et al. (2007). Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics, 39, 319-328.
101. Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M. & Südhof, T. C. (2007). A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science, 318, 71-76.
102. Tada, T. & Sheng, M. (2006). Molecular mechanisms of dendritic spine morphogenesis. Current Opinion in Neurobiology, 16, 95-101.
103. Talebizadeh, Z., Lam, D. Y., Theodoro, M. F., Bittel, D. C., Lushington, G. H. & Butler, M. G. (2006). Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. Journal of Medical Genetics, 43, e21.
104. Tassabehji, M., Metcalfe, K., Fergusson, W. D., Carette, M. J., Dore, J. K., Donnai, D., Read, A. P., Pröschel, C., Gutowski, N. J., Mao, X. & Sheer, D. (1996). LIM-kinase deleted in Williams syndrome. Nature Genetics, 13, 272-273.
105. Thomas, G. M. & Huganir, R. L. (2004). MAPK cascade signalling and synaptic plasticity. Nature Reviews Neuroscience, 5, 173-183.
106. Thomas, G. M., Lin, D. T., Nuriya, M. & Huganir, R. L. (2008). Rapid and bi-directional regulation of AMPA receptor phosphorylation and trafficking by JNK. EMBO Journal, 27, 361-372.
107. Threadgill, R., Bobb, K. & Ghosh, A. (1997). Regulation of dendritic growth and remodeling by Rho, Rac, and Cdc42. Neuron, 19, 625-634.
108. Walsh, T., et al. (2008). Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science, 320, 539-543.
109. Wu, F., Chen, Y., Li, Y., Ju, J., Wang, Z. & Yan, D. (2008). RNA-interference-mediated Cdc42 silencing down-regulates phosphorylation of STAT3 and suppresses growth in human 100. bladder-cancer cells. Biotechnology and Applied Biochemistry, 49, 121-128.
110. Wu, G. Y., Deisseroth, K. & Tsien, R. W. (2001). Spaced stimuli stabilize MAPK pathway activation and its effects on dendritic morphology. Nature Neuroscience, 4, 151-158.
111. Yan, J., Feng, J., Schroer, R., Li, W., Skinner, C., Schwartz, C. E., Cook, E. H. & Sommer, S. S. (2008a). Analysis of the neuroligin 4Y gene in patients with autism. Psychiatric Genetics, 18, 204-207.
112. Yan, J., Noltner, K., Feng, J., Li, W., Schroer, R., Skinner, C., Zeng, W., Schwartz, C. E. & Sommer, S. S. (2008b). Neurexin 1alpha structural variants associated with autism. Neuroscience Letters, 438, 368-370.
113. Yan, Y., Yang, D., Zarnowska, E. D., Du, Z., Werbel, B., Valliere, C., Pearce, R. A., Thomson, J. A. & Zhang, S. C. (2005). Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells, 23, 781-790.
114. Zahir, F. R., Baross, A., Delaney, A. D., Eydoux, P., Fernandes, N. D., Pugh, T., Marra, M. A. & Friedman, J. M. (2008). A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1alpha. Journal of Medical Genetics, 45, 239-243.
115. Zalfa, F., Eleuteri, B., Dickson, K. S., Mercaldo, V., De Rubeis, S., di Penta, A., Tabolacci, E., Chiurazzi, P., Neri, G., Grant, S. G. & Bagni, C. (2007). A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nature Neuroscience, 10, 578-587.
116. Zhu, Y., Pak, D., Qin, Y., McCormack, S. G., Kim, M. J., Baumgart, J. P., Velamoor, V., Auberson, Y. P., Osten, P., van Aelst, L., Sheng, M. & Zhu, J. J. (2005). Rap2-JNK removes synaptic AMPA receptors during depotentiation. Neuron, 46, 905-916.
117. Zhu, J. J., Qin, Y., Zhao, M., Van Aelst, L. & Malinow, R. (2002). Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell, 110, 443-455.
118. Zhu, X., Raina, A. K., Perry, G. & Smith, M. A. (2004). Alzheimer's disease: The two-hit hypothesis. Lancet Neurology, 3, 219-226.